PINK1-dependent recruitment of Parkin to mitochondria in mitophagy C Vives-Bauza, C Zhou, Y Huang, M Cui, RLA De Vries, J Kim, J May, ... Proceedings of the National Academy of Sciences 107 (1), 378-383, 2010 | 1841 | 2010 |
Mitophagy: the latest problem for Parkinson's disease C Vives-Bauza, S Przedborski Trends in molecular medicine 17 (3), 158-165, 2011 | 193 | 2011 |
The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells C Vives-Bauza, M Anand, AK Shirazi, J Magrane, J Gao, ... Journal of Biological Chemistry 283 (36), 24770-24780, 2008 | 183 | 2008 |
CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis EC Genin, M Plutino, S Bannwarth, E Villa, E Cisneros‐Barroso, M Roy, ... EMBO molecular medicine 8 (1), 58-72, 2016 | 182 | 2016 |
PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and α-synuclein aggregation in cell culture models of Parkinson's disease W Liu, C Vives-Bauza, A Yamamoto, Y Tan, Y Li, J Magrané, ... PloS one 4 (2), e4597, 2009 | 172 | 2009 |
Assay of mitochondrial ATP synthesis in animal cells and tissues C Vives‐Bauza, L Yang, G Manfredi Methods in cell biology 80, 155-171, 2007 | 120 | 2007 |
Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA C Vives-Bauza, R Gonzalo, G Manfredi, E Garcia-Arumi, AL Andreu Neuroscience letters 391 (3), 136-141, 2006 | 120 | 2006 |
Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene A Solano, M Roig, C Vives‐Bauza, J Hernandez‐Peña, E Garcia‐Arumi, ... Annals of Neurology: Official Journal of the American Neurological …, 2003 | 115 | 2003 |
Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies M Filosto, M Mancuso, C Vives‐Bauza, MR Vilà, S Shanske, M Hirano, ... Annals of Neurology: Official Journal of the American Neurological …, 2003 | 109 | 2003 |
Mitochondrial DNA background modifies the bioenergetics of NARP/MILS ATP6 mutant cells M D'aurelio, C Vives-Bauzà, MM Davidson, G Manfredi Human molecular genetics 19 (2), 374-386, 2010 | 100 | 2010 |
Measurements of the antioxidant enzyme activities of superoxide dismutase, catalase, and glutathione peroxidase C Vives‐Bauza, A Starkov, E Garcia‐Arumi Methods in cell biology 80, 379-393, 2007 | 98 | 2007 |
Sequence analysis of the entire mitochondrial genome in Parkinson's disease C Vives-Bauza, AL Andreu, G Manfredi, MF Beal, B Janetzky, ... Biochemical and biophysical research communications 290 (5), 1593-1601, 2002 | 85 | 2002 |
PINK1/Parkin direct mitochondria to autophagy C Vives-Bauza, RLA de Vries, M Tocilescu, S Przedborski Autophagy 6 (2), 315-316, 2010 | 71 | 2010 |
PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis M Mola-Caminal, C Carrera, C Soriano-Tárraga, E Giralt-Steinhauer, ... Circulation research 124 (1), 114-120, 2019 | 65 | 2019 |
Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders F Canellas, L Lin, MR Julià, A Clemente, C Vives-Bauza, HM Ollila, ... Journal of Clinical Sleep Medicine 10 (9), 1011-1018, 2014 | 64 | 2014 |
Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases EC Genin, S Bannwarth, F Lespinasse, B Ortega-Vila, K Fragaki, K Itoh, ... Neurobiology of disease 119, 159-171, 2018 | 53 | 2018 |
Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene L Palenzuela, C Vives-Bauza, I Fernandez-Cadenas, A Meseguer, N Font, ... Journal of medical genetics 39 (10), e67-e67, 2002 | 53 | 2002 |
Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative … E Piñero-Martos, B Ortega-Vila, J Pol-Fuster, E Cisneros-Barroso, ... Human molecular genetics 25 (19), 4157-4169, 2016 | 43 | 2016 |
Early neurological change after ischemic stroke is associated with 90-day outcome L Heitsch, L Ibanez, C Carrera, MM Binkley, D Strbian, T Tatlisumak, ... Stroke 52 (1), 132-141, 2021 | 42 | 2021 |
relapsing–remitting Multiple sclerosis is characterized by a T Follicular cell Pro-inflammatory shift, reverted by Dimethyl Fumarate Treatment V Cunill, M Massot, A Clemente, C Calles, V Andreu, V Núñez, ... Frontiers in immunology 9, 1097, 2018 | 40 | 2018 |